Transforming post pandemic cancer services

Br J Cancer. 2024 May;130(8):1233-1238. doi: 10.1038/s41416-024-02596-9. Epub 2024 Mar 15.

Abstract

This paper outlines the impact of the COVID-19 pandemic on cancer services in the UK including screening, symptomatic diagnosis, treatment pathways and projections on clinical outcomes as a result of these care disruptions. A restoration of cancer services to pre-pandemic levels is not likely to mitigate this adverse impact, particularly with an ageing population and increased cancer burden. New cancer cases are projected to rise to over 500,000 per year by 2035, with over 4 million people living with and beyond cancer. This paper calls for a strategic transformation to prioritise effort on the basis of available datasets and evidence-in particular, to prioritise cancers where an earlier diagnosis is feasible and clinically useful with a focus on mortality benefit by preventing emergency presentations by harnessing data and analytics. This could be delivered by a focus on underperforming groups/areas to try and reduce inequity, linking near real-time datasets with clinical decision support systems at the primary and secondary care levels, promoting the use of novel technologies to improve patient uptake of services, screening and diagnosis, and finally, upskilling and cross-skilling healthcare workers to expand supply of diagnostic and screening services.

Publication types

  • Review

MeSH terms

  • COVID-19* / epidemiology
  • Humans
  • Neoplasms* / diagnosis
  • Neoplasms* / epidemiology
  • Neoplasms* / therapy
  • Pandemics / prevention & control